These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 30277596)
1. KDM6B promotes ovarian cancer cell migration and invasion by induced transforming growth factor-β1 expression. Liang S; Yao Q; Wei D; Liu M; Geng F; Wang Q; Wang YS J Cell Biochem; 2019 Jan; 120(1):493-506. PubMed ID: 30277596 [TBL] [Abstract][Full Text] [Related]
2. TIPE2 inhibits the migration and invasion of epithelial ovarian cancer cells by targeting Smad2 to reverse TGF-β1-induced EMT. Tang Z; Zhang D; Yao C; Jiang M; Wang C; Chen Z; Yu H; Xue C; Liu Y; Shi Y; Zhang L; Wang X; Wei Z FASEB J; 2024 Sep; 38(17):e70045. PubMed ID: 39259551 [TBL] [Abstract][Full Text] [Related]
4. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition. Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796 [TBL] [Abstract][Full Text] [Related]
5. Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-β1-induced EMT and confers paclitaxel resistance in ovarian cancer. Wu X; Zhao J; Ruan Y; Sun L; Xu C; Jiang H Cell Death Dis; 2018 Oct; 9(11):1102. PubMed ID: 30375371 [TBL] [Abstract][Full Text] [Related]
6. KDM6B induces epithelial-mesenchymal transition and enhances clear cell renal cell carcinoma metastasis through the activation of SLUG. Li Q; Hou L; Ding G; Li Y; Wang J; Qian B; Sun J; Wang Q Int J Clin Exp Pathol; 2015; 8(6):6334-44. PubMed ID: 26261509 [TBL] [Abstract][Full Text] [Related]
7. The activation of microRNA-520h-associated TGF-β1/c-Myb/Smad7 axis promotes epithelial ovarian cancer progression. Zhang J; Liu W; Shen F; Ma X; Liu X; Tian F; Zeng W; Xi X; Lin Y Cell Death Dis; 2018 Aug; 9(9):884. PubMed ID: 30158641 [TBL] [Abstract][Full Text] [Related]
8. miR-146b promotes cell proliferation and increases chemosensitivity, but attenuates cell migration and invasion via FBXL10 in ovarian cancer. Yan M; Yang X; Shen R; Wu C; Wang H; Ye Q; Yang P; Zhang L; Chen M; Wan B; Zhang Q; Xia S; Lu X; Shao G; Zhou X; Yu J; Shao Q Cell Death Dis; 2018 Nov; 9(11):1123. PubMed ID: 30409964 [TBL] [Abstract][Full Text] [Related]
9. The histone H3 Lys 27 demethylase KDM6B promotes migration and invasion of glioma cells partly by regulating the expression of SNAI1. Sui A; Xu Y; Yang J; Pan B; Wu J; Guo T; Shen Y; Guo X Neurochem Int; 2019 Mar; 124():123-129. PubMed ID: 30633952 [TBL] [Abstract][Full Text] [Related]
10. Pyridoxine 5'-phosphate oxidase is a novel therapeutic target and regulated by the TGF-β signalling pathway in epithelial ovarian cancer. Zhang L; Zhou D; Guan W; Ren W; Sun W; Shi J; Lin Q; Zhang J; Qiao T; Ye Y; Wu Y; Zhang Y; Zuo X; Connor KL; Xu G Cell Death Dis; 2017 Dec; 8(12):3214. PubMed ID: 29238081 [TBL] [Abstract][Full Text] [Related]
11. P76RBE silencing inhibits ovarian cancer cell proliferation, migration, and invasion via suppressing the integrin β1/NF-κB pathway. Yan L; He Z; Li W; Liu N; Gao S Cell Cycle; 2021 Sep; 20(18):1875-1889. PubMed ID: 34382920 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer. Jin Y; Cui Z; Li X; Jin X; Peng J Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533 [TBL] [Abstract][Full Text] [Related]
13. High expression of SLC7A1 in high-grade serous ovarian cancer promotes tumor progression and is involved in MAPK/ERK pathway and EMT. You S; Han X; Xu Y; Sui L; Song K; Yao Q Cancer Med; 2024 May; 13(10):e7217. PubMed ID: 38752472 [TBL] [Abstract][Full Text] [Related]
14. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance. Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912 [TBL] [Abstract][Full Text] [Related]
15. JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells. Tang B; Qi G; Tang F; Yuan S; Wang Z; Liang X; Li B; Yu S; Liu J; Huang Q; Wei Y; Zhai R; Lei B; Yu H; Jiao X; He S Oncotarget; 2015 May; 6(14):12723-39. PubMed ID: 25909289 [TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition. Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177 [TBL] [Abstract][Full Text] [Related]
17. Stromal POSTN induced by TGF-β1 facilitates the migration and invasion of ovarian cancer. Yue H; Li W; Chen R; Wang J; Lu X; Li J Gynecol Oncol; 2021 Feb; 160(2):530-538. PubMed ID: 33317907 [TBL] [Abstract][Full Text] [Related]
18. TM4SF1 is a potential target for anti-invasion and metastasis in ovarian cancer. Gao C; Yao H; Liu H; Feng Y; Yang Z BMC Cancer; 2019 Mar; 19(1):237. PubMed ID: 30876464 [TBL] [Abstract][Full Text] [Related]
19. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression. Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904 [TBL] [Abstract][Full Text] [Related]
20. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo. He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]